Talk:GenesisCare

POV TAG

All the additions (significant) by user phillipa.sherriff are written like an advert, which is not surprising considering who she is. https://www.linkedin.com/in/phillipa-sherriff/

Note that no references are provided either.

I tried to "undo" her additions, but could not. I may well just revert to the version prior to her revisions, unless someone has a better idea?

MarmotteiNoZ 11:13, 29 October 2020 (UTC)

The current web page of the (Australian) company https://www.genesiscare.com/au/about-us-our-vision-and-values/ asserts quite a large USA business - larger than the international business. It says nothing about ownership. So this page may possibly be significantly out of date. Perhaps the Media department of Genesis could assign somebody to update it. — Preceding unsigned comment added by 2001:8004:2728:1395:7D4F:62CB:6501:C0EA (talk) 05:11, 18 March 2021 (UTC)

Edit request

Thank you for reviewing my original request.

Following the feedback received, I have revised the proposed replacement article so that each factual statement is supported by inline references using Wikipedia tags.

The current article contains substantial historical information relating to GenesisCare's former international operations and no longer reflects the organisation following its 2024 corporate reorganisation. The proposed replacement updates the article to reflect the current Australian organisation while retaining a concise summary of its international history.

Proposed replacement

GenesisCare is an Australian private provider of cancer care services specialising in radiation therapy, medical oncology, theranostics and personalised medicine. The organisation operates more than 50 centres across Australia and treats more than 35,000 patients each year. It employs more than 1,900 staff, including over 270 doctors.

GenesisCare is one of Australia's largest private providers of radiation oncology services.

History

GenesisCare was founded in Australia in 2005 and expanded through a combination of organic growth and acquisitions to become one of Australia's largest private providers of cancer care services.

The organisation subsequently expanded internationally, establishing operations in the United Kingdom, Spain and the United States. Following a corporate reorganisation completed in 2024, GenesisCare Australia, GenesisCare UK and GenesisCare Spain became independently managed businesses with separate governance structures.

Services

GenesisCare provides radiation therapy, medical oncology, theranostics and personalised medicine services across Australia.

Radiation therapy

Radiation therapy services include stereotactic ablative radiation therapy (SABR), image-guided radiation therapy and MRI-guided radiation therapy using MR-Linac technology.

GenesisCare also provides low-dose radiation therapy for selected benign (non-cancerous) conditions including osteoarthritis, Dupuytren's disease, Ledderhose disease, keloid scars and plantar fasciitis.

Medical oncology

GenesisCare provides medical oncology services in New South Wales, South Australia and Western Australia. Services include chemotherapy, hormone therapy, immunotherapy, targeted therapies and haematology.

Theranostics

GenesisCare provides theranostics, a treatment approach that combines diagnostic imaging with targeted radionuclide therapy for selected cancers.

Personalised medicine

GenesisCare provides personalised medicine services, including prognostic and predictive testing to support treatment planning based on individual patient and tumour characteristics.

Support services

GenesisCare clinicians participate in multidisciplinary team (MDT) meetings and work with allied health providers as part of patient care. Depending on location, patients may also have access to specialist nursing services, breast wellness clinics and allied health professionals including psychologists, physiotherapists, dietitians and lymphoedema therapists.

Research

GenesisCare conducts clinical research and clinical trials across radiation oncology, medical oncology, theranostics and haematology as part of its cancer care services.

Research is conducted through a national network of centres and includes both investigator-initiated and externally sponsored studies.

According to the organisation's 2025 Annual Research Report, GenesisCare managed 217 active research projects across Australia, including interventional and observational studies in radiation oncology, medical oncology, theranostics and haematology. The research program involved more than 40 dedicated research staff and operated across 52 clinics nationally.

The report also states that GenesisCare contributed to more than 80 external research initiatives and clinical quality registries and produced 62 peer-reviewed publications during 2025.

Research activities include clinical trials in radiation oncology, medical oncology, theranostics and haematology, together with studies investigating MRI-guided radiation therapy and radiation therapy for benign conditions.

Locations

GenesisCare operates more than 50 centres across New South Wales, Queensland, Victoria, South Australia and Western Australia, providing a combination of radiation therapy, medical oncology, theranostics and haematology services depending on location.